Suppression of disease causingnonsense mutations by targeted mRNA pseudouridylation
通过靶向 mRNA 假尿苷化抑制引起无义突变的疾病
基本信息
- 批准号:9805188
- 负责人:
- 金额:$ 16.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:Aminoglycoside AntibioticsAnticodonApplications GrantsAttentionBreast CarcinomaCancer EtiologyCancer cell lineCell LineCellsClinicalCodeCodon NucleotidesCoupledCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDevelopmentDiseaseElementsEngineeringEnzymesEpithelial CellsGenesGenetic DiseasesGenetic TranscriptionGoalsHumanHuman GeneticsInheritedLengthMalignant NeoplasmsMass Spectrum AnalysisMeasuresMediatingMessenger RNAModificationMonitorMutationNonsense CodonNonsense MutationNucleoplasmNucleotidesPrimer ExtensionProductionProtein p53ProteinsPseudouridineRNAReporter GenesReverse Transcriptase Polymerase Chain ReactionRibosomal RNARibosomesSignal TransductionSiteSmall Nuclear RNASpecificityStep TestsStructureSystemTP53 geneTerminator CodonTestingTransfectionTransfer RNATranslationsUntranslated RNAUridineWorkYeastsbeta Globincancer typechemical propertyclinically relevantcystic fibrosis patientsestablished cell lineexperiencehuman diseaseimprovedmRNA Decaynovel strategiesnovel therapeuticsprematurerelease factor
项目摘要
In this exploratory grant application, we propose to fully develop a novel approach, namely, targeted
RNA pseudouridylation, to suppress nonsense mutations in genes that cause diseases (e.g.,
nonsense mutations in the CFTR gene that cause Cystic Fibrosis, and nonsense mutations in p53
gene that cause various types of cancer). This project, if successful, will constitute a giant step
toward our ultimate goal of developing novel therapeutic treatment for a number of genetic disorders
and certain types of cancer caused by nonsense mutations. We propose to carry out this project
under two specific aims.
Aim 1. To improve the efficiency of RNA-guided pseudouridylation in human cells. We will improve
the efficiency of targeted mRNA pseudouridylation by identifying a better modifying enzyme
(specifically, a better box H/ACA guide RNA). We will focus on the three elements within the guide
RNA that have been identified (by our lab and other labs) to be important for directing
pseudouridylation, and construct a perfect box H/ACA guide RNA. We will also engineer the guide
RNA by adding a nucleoplasmic localization signal, thus targeting the guide RNA (and RNP) to the
nucleoplasm where mRNA is synthesized and matures. Finally, we will increase box H/ACA RNA
expression level, thus raising its concentration in the nucleoplasm of human cells. In doing so, we
believe we will be able to create a super guide RNA that can efficiently direct site-specific mRNA
pseudouridylation.
Aim 2. To directly target the PTC within a disease gene in human disease cell lines. Using an
designer box H/ACA RNA (especially when the improved super box H/ACA RNA identified in Aim 1
is available), we will directly target the premature termination codon (PTC, resulting from nonsense
mutations) within the CFTR mRNA in a CF cell line and within the p53 mRNA in a human cancer cell
line. The efficiency of guide RNA transfection and its expression level in transfected cells will be
measured. Site-specific pseudouridylation at the PTC of mRNAs will also be quantified. Furthermore,
nonsense suppression, including the suppression of NMD (nonsense-mediated mRNA decay) and
PTC read-through, will be monitored. In short, this proposal presents a potential novel approach to
treat many genetic diseases and certain types of cancer associated with nonsense mutations.
在这个探索性的赠款申请中,我们建议充分开发一种新的方法,即有针对性的
RNA假尿苷酸化,以抑制引起疾病的基因中的无义突变(例如,
导致囊性纤维化的CFTR基因无义突变,以及p53基因无义突变
导致各种癌症的基因)。这个项目,如果成功,将是一个巨大的进步,
我们的最终目标是为一些遗传性疾病开发新的治疗方法,
和某些由无义突变引起的癌症。我们建议实施这个项目
有两个具体目标。
目标1.提高人细胞中RNA引导的假尿苷酸化的效率。完善
通过鉴定更好的修饰酶来提高靶向mRNA假尿苷化的效率
(具体地,更好的盒H/ACA引导RNA)。我们将重点介绍指南中的三个要素
RNA已被确定(由我们的实验室和其他实验室)是重要的指导
假尿苷酸化,并构建完美盒H/ACA引导RNA。我们还将设计指南
通过添加核质定位信号,从而将引导RNA(和RNP)靶向至靶向RNA,
核质,mRNA在此合成并成熟。最后,我们将增加盒H/ACA RNA
表达水平,从而提高其在人细胞核质中的浓度。这样做
我相信我们将能够创造一种超级指导RNA,可以有效地指导位点特异性mRNA
假尿苷化
目标2.直接靶向人类疾病细胞系中疾病基因内的PTC。使用
设计者盒H/ACA RNA(特别是当Aim 1中鉴定的改进的超级盒H/ACA RNA
可用),我们将直接靶向提前终止密码子(PTC,由无义产生
在CF细胞系中的CFTR mRNA内和在人癌细胞中的p53 mRNA内
线指导RNA转染的效率和其在转染细胞中的表达水平将被评估。
测定了还将定量mRNA PTC处的位点特异性假尿苷化。此外,委员会认为,
无义抑制,包括抑制NMD(无义介导的mRNA衰变),
将监测PTC通读。简而言之,该提案提出了一种潜在的新方法,
治疗许多与无义突变相关的遗传疾病和某些类型的癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YI-TAO YU其他文献
YI-TAO YU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YI-TAO YU', 18)}}的其他基金
Pseudouridine-mediated branch site recognition/selection during pre-mRNA splicing
前 mRNA 剪接过程中假尿苷介导的分支位点识别/选择
- 批准号:
10383755 - 财政年份:2020
- 资助金额:
$ 16.75万 - 项目类别:
Pseudouridine-mediated branch site recognition/selection during pre-mRNA splicing
前 mRNA 剪接过程中假尿苷介导的分支位点识别/选择
- 批准号:
10612829 - 财政年份:2020
- 资助金额:
$ 16.75万 - 项目类别:
Pseudouridine-mediated branch site recognition/selection during pre-mRNA splicing
前 mRNA 剪接过程中假尿苷介导的分支位点识别/选择
- 批准号:
10231213 - 财政年份:2020
- 资助金额:
$ 16.75万 - 项目类别:
Pseudouridine-mediated branch site recognition/selection during pre-mRNA splicing
前 mRNA 剪接过程中假尿苷介导的分支位点识别/选择
- 批准号:
10026485 - 财政年份:2020
- 资助金额:
$ 16.75万 - 项目类别:
Expanding the genetic code by targeted pseudouridylation
通过靶向假尿苷化扩展遗传密码
- 批准号:
8550118 - 财政年份:2012
- 资助金额:
$ 16.75万 - 项目类别:
Expanding the genetic code by targeted pseudouridylation
通过靶向假尿苷化扩展遗传密码
- 批准号:
8419298 - 财政年份:2012
- 资助金额:
$ 16.75万 - 项目类别:
Regulation of telomerase activity and aging by 2'-O-methylation in telomerase RNA
端粒酶RNA中2-O-甲基化对端粒酶活性和衰老的调节
- 批准号:
8516934 - 财政年份:2012
- 资助金额:
$ 16.75万 - 项目类别:
Expanding the genetic code by targeted pseudouridylation
通过靶向假尿苷化扩展遗传密码
- 批准号:
8914641 - 财政年份:2012
- 资助金额:
$ 16.75万 - 项目类别:
Expanding the genetic code by targeted pseudouridylation
通过靶向假尿苷化扩展遗传密码
- 批准号:
8720024 - 财政年份:2012
- 资助金额:
$ 16.75万 - 项目类别:
Regulation of telomerase activity and aging by 2'-O-methylation in telomerase RNA
端粒酶RNA中2-O-甲基化对端粒酶活性和衰老的调节
- 批准号:
8242209 - 财政年份:2012
- 资助金额:
$ 16.75万 - 项目类别:
相似海外基金
Determining how 2'-O-methylations in the eukaryotic anticodon loop region of tRNA are formed and how they affect translation
确定 tRNA 真核反密码子环区域中 2-O-甲基化的形成方式以及它们如何影响翻译
- 批准号:
10438971 - 财政年份:2018
- 资助金额:
$ 16.75万 - 项目类别:
Elucidation of reaction mechanism for post-transcriptional modification at tRNA anticodon region
阐明 tRNA 反密码子区域转录后修饰的反应机制
- 批准号:
20687007 - 财政年份:2008
- 资助金额:
$ 16.75万 - 项目类别:
Grant-in-Aid for Young Scientists (A)
Codon-anticodon coevolution in invertebrate mitochondrial genomes
无脊椎动物线粒体基因组中的密码子-反密码子协同进化
- 批准号:
370096-2008 - 财政年份:2008
- 资助金额:
$ 16.75万 - 项目类别:
University Undergraduate Student Research Awards
Role of the Elongator complex in tRNA anticodon modification and intracellular stress signaling (B02)
Elongator 复合物在 tRNA 反密码子修饰和细胞内应激信号传导中的作用 (B02)
- 批准号:
5447893 - 财政年份:2005
- 资助金额:
$ 16.75万 - 项目类别:
Collaborative Research Centres
THE ANTICODON AND ITS INFLUENCE ON TRNA IDENTITY
反密码子及其对 TRNA 身份的影响
- 批准号:
3045064 - 财政年份:1990
- 资助金额:
$ 16.75万 - 项目类别:
THE ANTICODON AND ITS INFLUENCE ON TRNA IDENTITY
反密码子及其对 TRNA 身份的影响
- 批准号:
3045063 - 财政年份:1990
- 资助金额:
$ 16.75万 - 项目类别:
Study on the biosynthesis of the modified uridine derivatives at the first position of the anticodon of tRNA
tRNA反密码子第一位修饰尿苷衍生物的生物合成研究
- 批准号:
61571061 - 财政年份:1986
- 资助金额:
$ 16.75万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)














{{item.name}}会员




